Cite

HARVARD Citation

    Nasir, M. et al. (2022). Impact of rituximab regime on time to relapse in aquaporin-4 antibody positive neuromyelitis spectrum disorder. Journal of neurology, neurosurgery and psychiatry. 93 (9), pp. e2-. [Online]. 
  
Back to record